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Abstract Annotation on the reference genome of the
C57BL6/J mouse has been an ongoing project ever since the
draft genome was first published. Initially, the principle
focus was on the identification of all protein-coding genes,
although today the importance of describing long non-cod-
ing RNAs, small RNAs, and pseudogenes is recognized.
Here, we describe the progress of the GENCODE mouse
annotation project, which combines manual annotation from
the HAVANA group with Ensembl computational annota-
tion, alongside experimental and in silico validation pipeli-
nes from other members of the consortium. We discuss the
more recent incorporation of next-generation sequencing
datasets into this workflow, including the usage of mass-
spectrometry data to potentially identify novel protein-
coding genes. Finally, we will outline how the C57BL6/J
genebuild can be used to gain insights into the variant sites
that distinguish different mouse strains and species.
The fundamentals of gene annotation
The value of the mouse genome as a resource largely
depends on the quality of the accompanying gene annota-
tion. In this context, ‘annotation’ is defined as the process
of identifying and describing gene structures. However, in
the 21st century, genes are increasingly regarded as col-
lections of distinct transcripts—generated, most obviously,
by alternative splicing—that can have biologically distinct
roles (Gerstein et al. 2007). The process of ‘gene’ anno-
tation is therefore perhaps more accurately understood as
that of ‘transcript’ annotation (with separate consideration
being given to pseudogene annotation). The information
held in such models can be divided into two categories.
Firstly, the model will contain the coordinates of the
transcript structure, i.e., the coordinates of exon/intron
architecture and splice sites, as well as the transcript start
site (TSS) and polyadenylation site (if known; see ‘‘The
incorporation of next-generation sequencing technologies
into mouse annotation’’ section). Secondly, for a transcript
model to have value, it must also contain some level of
‘functional’ annotation (Mudge et al. 2013); for example, a
model may contain the location of a translated region
(coding sequence; CDS), alongside flanking untranslated
regions (UTRs). However, our understanding of the
mammalian transcriptome has evolved rapidly since the
genome-sequencing era began. For example, the classical
tRNA and rRNA families of small RNA (smRNA) are
being joined by an ever increasing number of novel cate-
gories, including miRNAs, snoRNAs, and piwiRNAs
(Morris and Mattick 2014). Of particularly interest is the
discovery of thousands of long non-coding RNA (lncRNA)
loci in mammalian genomes, with much of the pioneering
work having being done in mouse (Carninci et al. 2005).
LncRNAs—typically defined as non-coding, non-pseuo-
dogenic transcripts larger than 200 bp—have been gener-
ally linked to the control of gene expression pathways,
although a single functional paradigm seems unlikely to be
established (Marques and Ponting 2014; Morris and Mat-
tick 2014; Vance and Ponting 2014). In addition,
Electronic supplementary material The online version of this
article (doi:10.1007/s00335-015-9583-x) contains supplementary
material, which is available to authorized users.




1 Wellcome Trust Sanger Institute, Cambridge, UK
123
Mamm Genome (2015) 26:366–378
DOI 10.1007/s00335-015-9583-x
pseudogenes—commonly described as deactivated copies
of existing protein-coding genes—have long been a target
for annotation projects (Frankish and Harrow 2014; Pruitt
et al. 2014), and such loci can actually contribute to the
transcriptome through their expression (Pei et al. 2012).
Nonetheless, debate persists as to the proportion of the
transcriptome that could be defined as spurious ‘noise,’
resulting from the essentially stochastic nature of tran-
scription and splicing (Hangauer et al. 2013).
Certainly, annotation projects are under increasing pres-
sure to provide users access to the portion of the transcrip-
tome that is truly ‘functional’ (Mudge et al. 2013). In recent
years, this process has become empowered by the advent of
next-generation technologies. For example, RNAseq can be
used to identify novel transcripts and to provide insights into
their functionality (Wang et al. 2009), while proteomics data
may allow us to finally understand the true size of mam-
malian proteomes (Nesvizhskii 2014). Annotation, in short,
remains a work in progress, and the major challenge for the
future will be to maintain the utility of the reference gene
data, while providing a set of models that are an increasingly
true representation of the transcriptome as it exists in nature.
Here, we provide an outline of how the GENCODE project
is continuing to produce comprehensive gene annotation for
the reference genome of Mus musculus.
Mouse GENCODE combines manual
and computational annotation
The GENCODE project originated as an integral part of the
human ENCODE project, where its remit was to identify
all ‘evidence-based’ gene features found within the human
genome (ENCODE Project Consortium et al. 2012; Harrow
et al. 2012). More specifically, the goal of mouse GEN-
CODE is the description of all non-redundant transcripts
associated with protein-coding genes and non-coding
RNAs (small and long), along with the identification of all
pseudogenes. Eight institutes contribute to the project (see
Acknowledgments), bringing together expertise in anno-
tation, computational transcriptomics, experimental vali-
dation, comparative analysis, protein structure, and mass
spectrometry (MS). Figure 1 summarizes the workflow of
the GENCODE project. At the core of this process is
manual gene annotation produced by the HAVANA group,
whereby bespoke interactive software tools are used to
create and appraise the alignments of a wide range of data
sources—chiefly transcriptomics and proteomics data—
against the genome sequence (Harrow et al. 2012; Harrow
et al. 2014). To complement this work, Ensembl generates
a mouse gene annotation set (henceforth ‘genebuild’) via
an entirely computational process, although using similar
evidence sources (Cunningham et al. 2015).
Both HAVANA and Ensembl thus build models onto the
genome sequence, rather than onto transcript evidence. A
disadvantage of this process is that any errors found in the
genome sequence will be carried over as errors in the
models. However, there are also significant reasons why
genome annotation is desirable. In particular, the use of a
genome scaffold for the alignment of transcriptional evi-
dence allows for a wider variety of evidence sources to be
used, including those that do not represent complete tran-
scripts, e.g. expressed sequence tags (ESTs). Genome
annotation is also better suited for the identification of
pseudogenes (which may not be transcribed) (Pei et al.
2012), and can be advantageous for the interpretation of
next-generation sequencing (NGS) data, as will be dis-
cussed in ‘‘The incorporation of next-generation sequenc-
ing technologies into mouse annotation’’ section. In fact,
since HAVANA annotation is fully manual there is effec-
tively no limit to the number of additional evidence sources
that may be consulted. For example, publications based on
single-locus laboratory studies often contain insights that
cannot be accommodated into computational annotation
pipelines, though can be effectively ‘curated’ by annota-
tors. Critically, in-depth comparative annotation is also
possible with the manual approach. This process, which
essentially involves comparing the mouse genome and
transcriptome against those of other species, has two major
benefits. Firstly, the annotation of transcript features such
as CDS can be performed (where required) with a higher
degree of confidence by following the old argument that
‘conservation equals function.’ Secondly, HAVANA fre-
quently annotates mouse models based on transcript evi-
dence from other species—typically human or rat—when
conservation is observed, thus providing additional models
that seem likely to be functional.
The key stage in the creation of the GENCODE
genebuild is the merging of the HAVANA and Ensembl
datasets (Fig. 1). A new release is generated each time the
Ensembl pipeline is re-run, approximately every three
months (Harrow et al. 2012). In essence, this process
merges transcripts from the two datasets that contain
identical intron/exon boundaries, while maintaining models
that are found in one set only. The logic behind the merge
is that, while manually annotation has higher precision than
computational annotation (Guigo et al. 2006), it is a much
slower process. Ensembl annotation thus ‘fills in the gaps,’
covering genes and transcripts that have not yet been tar-
geted by HAVANA. Prior to each merge process, the
AnnoTrack software system is used by HAVANA to pro-
cess and track both potential annotation errors and putative
novel annotations suggested by the Ensembl genebuild or
other GENCODE participants (Kokocinski et al. 2010).
Finally, the Ensembl pipeline provides the annotation of
smRNAs, based on datasets from RFAM (Griffiths-Jones
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et al. 2003) and miRBase (Griffiths-Jones et al. 2006).
These sequences are queried against the genome with WU-
BLAST, and models are constructed using the Infernal
software suite (Eddy 2002).
Table 1 provides summary information on the most
recent mouse GENCODE release (M5), with equivalent
information provided from human GENCODE v22 for
comparison. A fully comprehensive summary of the mouse
release is presented in Supplementary Table 1. While the
HAVANA group has performed manual annotation on the
entirety of the human reference genome, the same is not
true for the mouse genome. As such, the proportion of
mouse GENCODE models that are computationally
derived is higher than for the human genebuild. For
example, 1 % of protein-coding genes and 11 % of protein-
coding transcripts in human are Ensembl-only, compared
with 26 % and 20 % in mouse, respectively. It is this
factor—rather than underlying biological differences
between the two species—that is likely to explain the more
obvious tallying divergences. Firstly, the HAVANA group
has thus far allocated more resources to the annotation of
lncRNAs and pseudogenes in human than in mouse (Der-
rien et al. 2012; Pei et al. 2012). Conversely, mouse
GENCODE currently has over 2000 more protein-coding
genes than human. While this observation may actually
have at least a partial biological explanation—most obvi-
ously, the mouse olfactory gene family is substantially
larger than in human (Niimura and Nei 2005)—we
anticipate that a significant part of this excess represents
either spurious computational CDS predictions on
lncRNAs or loci that will be re-annotated as pseudogenes
in due course.
Thus far, the HAVANA group has approached mouse
annotation from a variety of directions. Initially, four
chromosomes sequenced at the Wellcome Trust Sanger
Institute (2, 4, 11, and X) were systematically annotated on
a clone-by-clone basis during the assembly phase. Sec-
ondly, numerous genomic regions and gene families con-
sidered of particular interest to the wider community had
their annotation prioritized, for example, the major histo-
compatibility complex on chr17 (unpublished), the Major
Urinary Proteins gene cluster on chr 4 (Mudge et al. 2008)
and the large complement of immunoglobulin loci found at
several sites across the genome (unpublished). The
HAVANA group has also been involved in several col-
laborative projects over the years that have required
annotation on a gene-by-gene basis. Examples include the
consensus CDS project (CCDS) (Farrell et al. 2014), which
produces a set of CDS that are agreed upon by HAVANA,
Ensembl and RefSeq, and the European Conditional
Knockout Mouse Consortium (EUCOMM), in which 1000
mouse protein-coding genes were annotated as part of the
wider International Knockout Mouse Consortium (IKMC)
to aid phenotype-based investigations into their function
(Bradley et al. 2012). Currently, the HAVANA group is
funded by the GENCODE consortium to resume systematic
Fig. 1 An overview of the mouse GENCODE annotation pipeline.
While the HAVANA and Ensembl workflows are largely based on the
alignment of Sanger-sequenced cDNAs/ESTs and protein sequences
against the genome, the gene-by-gene nature of HAVANA annotation
allows for further evidence sources to be incorporated. Important
contributions are also made from other institutions that are part of the
GENCODE project. Briefly, a subset of models are being subjected to
experimental confirmation via RT-PCRseq and RACE-seq (Howald
et al. 2012), in silico pseudogene models predicted using Pseudopipe
(Zhang et al. 2006) and Retrofinder from UCSC are used to
complement manual annotation, while the APPRIS database is used
to provided inferences into the likely ‘principal variant’ of individual
loci (Rodriguez et al. 2013). These contributions are monitored by
HAVANA using the AnnoTrack software, which is also used to
facilitate the identification and correction of putative annotation errors
(Kokocinski et al. 2010)
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chromosome annotation. Efforts are largely focused on loci
not already covered by the EUCOMM/IKMC or CCDS
work, which are typically lncRNAs and pseudogenes.
However, improvements to protein-coding genes are being
made as required.
GENCODE annotation is presented as default in the
Ensembl genome browser (see Fig. 2a), In addition, the
GENCODE webportal (www.genecodegenes.org) features
an embedment of the Biodalliance genome visualization
tool (Fig. 2b), allowing users to create their own integrated
view of GENCODE transcript models alongside their own
experimental datasets (Down et al. 2011). GENCODE can
Table 1 A summary of mouse GENCODE annotation release 5, compared against human 22
Images have been collated from the GENCODE webportal (www.gencodegenes.org), which is immediately updated for each new genebuild
release. Only major annotation categories or summary counts are shown here; for more detailed counts—e.g., relating to individual long non-
coding RNA loci, transcribed versus non-transcribed pseudogenes, immunoglobulin/T cell receptor loci, etc—please consult Supplementary
Table 1 or the webportal. Note that the difference in the number of protein-coding transcripts versus the total number of distinct translations
within each genebuild is due to the existence of identical CDS on multiple models, typically resulting from alternative splicing within
untranslated regions
cFig. 2 Viewing mouse GENCODE annotation in the Ensembl,
Biodalliance, and UCSC genome browsers. Mouse GENCODE is
the default annotation in the Ensembl genome browser (a), while the
GENCODE webportal contains an embedment of the Biodalliance
genome visualization tool (b). Both browsers will always feature the
most up-to-date genebuild. GENCODE can also be viewed in the
UCSC genome browser (c; the ‘UCSC Genes’ and ‘RefSeq Genes’
annotation tracks are shown for comparison), although a new release
does not become immediately available; version M4 is displayed here.
In each screenshot, the ‘Comprehensive’ GENCODE annotation is
presented for the adjacent genes Cox11 and Tom1l1, thus showing all
GENCODE models associated with these loci. The Ensembl and
UCSC browser screenshots also display the Consensus Coding
Sequence (CCDS) project models for these loci (Farrell et al.
2014), colored green in both cases
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also be viewed in the UCSC genome browser (Rosenbloom
et al. 2015) (Fig. 2c). In contrast, HAVANA manual
annotation alone is represented in the specially designated
VEGA genome browser (Harrow et al. 2014). Since this
annotation is continually updated, VEGA provides users
with access to the most up-to-date HAVANA models prior
to the each GENCODE release. The genebuild itself can be
obtained from the GENCODE webportal or from the
Ensembl site (Cunningham et al. 2015). The GENCODE
genebuild is currently available as a GTF file in two forms,
‘Comprehensive’ and ‘Basic’ (Harrow et al. 2012). While
Comprehensive includes all GENCODE annotation, Basic
contains only full-length coding transcripts (i.e., where
initiation and termination codons are found), and tran-
scripts annotated with one of the subcategories of lncRNA.
One of the major advantages of the GENCODE genebuild
is that it contains a sophisticated system of gene-level and
transcript-level classifications—termed ‘biotypes’—as
summarized in Supplementary Table 1. Essentially, gene-
level classification separates protein-coding genes,
lncRNAs, and pseudogenes, while the wider variety of
transcript biotypes provides inferences into the function-
ality of individual models (Harrow et al. 2012). Of par-
ticular note, GENCODE (unlike other genebuilds)
describes transcripts likely to be targeted for degradation
by the nonsense-mediated decay surveillance pathway
(NMD) (Mendell et al. 2004). NMD models are manually
annotated, and contain the CDS predicted to trigger this
process. GENCODE biotypes can be also used to filter the
genebuild; for example, a user may wish to discard all
transcripts associated with protein-coding genes that are
not themselves annotated as protein-coding. GENCODE
also contains a number of fixed-vocabulary ‘attributes’
attached to particular genes or transcript models within the
GTF file. Attributes fall into three categories—pertaining
to splicing, translation, or transcriptional support—and
provide additional insights into the annotation of a gene or
transcript model. For a full list of GENCODE attributes,
consult the release notes provided at the GENCODE
webportal. Finally, the GTF file also reports whether a
model has been created by the manual annotation process
or is instead a computational prediction. Note that when
HAVANA and Ensembl biotypes conflict during the merge
of particular models, the HAVANA decision is given
priority.
The incorporation of next-generation sequencing
technologies into mouse annotation
HAVANA and Ensembl annotation efforts on the mouse
draft genome sequence began in 2000. For most of this first
decade, annotation was almost entirely based on Sanger-
sequenced transcriptomics data, i.e., all publically available
cDNAs/mRNAs and ESTs. In more recent years, next-
generation technologies have transformed RNA sequencing
(Robertson et al. 2010), and these datasets offer the
potential to similarly transform the annotation process.
Nonetheless, the nature of these datasets provides chal-
lenges for such endeavors, largely because (1) the amount
of data produced in a typical NGS experiment is enormous,
and (2) NGS reads (especially those produced by the first
wave of sequencing platforms) are typically far shorter
than the RNAs from which they are captured, complicating
efforts to map these reads to the genome and to generate
full-length transcript models (Engstrom et al. 2013; Stei-
jger et al. 2013). It would be fair to say that the compu-
tational difficulties inherent in NGS data analysis continue
to place limitations on the incorporation of these resources
into annotation projects. Nonetheless, mouse GENCODE
currently benefits from the inclusion of NGS data from a
variety of sources. Most obviously, RNAseq can provide
the core evidence of transcribed regions, including splice
junctions, while CAGE (Cap Analysis of Gene Expression)
and polyadenylation sequencing (polyAseq) allow for the
transcription start and end points, respectively, to be con-
firmed. The CAGE protocol specifically targets the 50
capped region of RNA molecules, generating large datasets
of short sequence tags that can be mapped to the genome
and used to infer the locations of transcription start sites
(TSS) (Shiraki et al. 2003; Takahashi et al. 2012). In par-
ticular, the FANTOM consortium has generated extensive,
tissue-specific mouse CAGE libraries as part of the FAN-
TOM5 project (Forrest et al. 2014) (see also de Hoon et al.
in this issue). Analogously, the polyAseq protocol as used
by Derti et al. targets the site of RNA molecules where the
polyadenylation tail is added to the maturing transcript
(Derti et al. 2012). As for CAGE, large numbers of short
sequence reads are mapped onto the genome and extrapo-
lated into polyadenylation sites.
From the outset, NGS sequencing data can benefit
genebuilds both by identifying new genes and transcripts
and by allowing for improvements to be made to existing
models. Such improvements may involve the completion of
partial models, although NGS datasets can also provide
significant insights into how (or indeed if) transcripts
actually function. These inferences can then be passed onto
users through the GENCODE functional annotation sys-
tem, as described in ‘‘Mouse GENCODE combines manual
and computational annotation’’ section. The novel genes
being added to mouse GENCODE as part of this work are
almost entirely lncRNAs. Figure 3 illustrates the annota-
tion of one such locus. In this example, RNAseq data
processed by Ensembl and/or the Centre de Regulacio´
Geno`mica (CRG) highlighted potential novel introns
within a HAVANA lncRNA, and this locus was subjected
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to manual re-annotation. Transcript A alone had been
created initially, based on two cDNAs, while transcript B
was annotated later based on the NGS datasets. The two
introns of transcript B are supported by two RNAseq
studies, although since these experiments used short
RNAseq reads, a further level of manual interpretation was
required to extrapolate complete transcript structures.
Transcript B was considered a reasonable extrapolation
because in one RNAseq dataset set the two introns are
found in spleen and thymus tissues. In contrast, the longer
second intron found in the same set was not converted into
annotation as it is only found weakly expressed in a single
tissue and is not recapitulated in the ENCODE data. The
manual process also allowed the lack of coding potential to
be reappraised—the putative ORFs suggested in certain of
the RNAseq models were rejected as spurious—and the
gene was ‘biotyped’ as an antisense lncRNA. In contrast,
Fig. 4 details the re-annotation of a mouse lncRNA into
protein-coding gene Naaladl2. In this example, a large
protein-coding gene was not originally apparent due to a
lack of cDNAs or ESTs in the region. In fact, a short,
single-transcript gene was initially annotated in the region,
biotyped as a non-coding model because a plausible CDS
could not be identified. When reappraised, a comparative
analysis made it clear that this transcript was partially
orthologous to human protein-coding gene NAALADL2,
and that each of these additional human introns has support
in mouse RNAseq libraries. This allowed for the con-
struction of a conserved 795aa protein-coding transcript in
mouse, while the original lncRNA transcript could now be
seen to be a non-coding alternative transcript. In addition, it
proved possible to extrapolate the true extent of the final
exon by manually appraising RNAseq read coverage
graphs alongside polyAseq data (Fig. 4b).
As noted in ‘‘Mouse GENCODE combines manual and
computational annotation’’ section, GENCODE contains a
Fig. 3 The NGS-supported annotation of a novel mouse lncRNA
locus. Two HAVANA-annotated lncRNAs transcripts
(A OTTMUST00000139812; B OTTMUST00000020448) found
within the same gene (OTTMUSG00000009012) are displayed.
Model A was annotated initially, based on Sanger-sequenced
transcriptomics data; model B was subsequently added based on the
NGS data. These supporting evidence sets are displayed below as
follows, from top to bottom: mouse ESTs; mouse cDNAs; introns
supported by Illumina RNAseq data (i.e., split reads) obtained
separately from David Adams at WTSI (red; ArrayExpress ID:
E-MTAB-599) and ENCODE (purple), both processed by the
Ensembl RNAseq pipeline; RNAseq models based on ENCODE
data, separately constructed using the Ensembl and CRG RNAseq
pipelines; polyAseq site and filtered CAGE transcription start site
regions predicted by Derti et al. (Gene Expression Omnibus ID:
GSE30198) and FANTOM (DDBJ accession: DRA000991), respec-
tively. The presence of CAGE and polyAseq data at the start and end
point of transcript B confirms that the complete model has been
annotated
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large number of incomplete models, and RNAseq data can
now be used to ‘complete’ these. While the presence of
partial models in GENCODE allows users to work with
exons and splice junctions that may nonetheless be bio-
logically important, one issue is that the functional anno-
tation of such models tends to be more predictive. In fact,
even when a model is based on a cDNA, it cannot be
assumed that the sequence captured is full-length, i.e.,
contains the true TSS or endpoint. However, the observa-
tion of significant CAGE data at the beginning of other
transcript evidence can be used to confirm that the TSS has
been found, adding confidence to the subsequent functional
annotation. For example, in Fig. 3, the presence of CAGE
data at the start of model B indicates that exons are not
missing at the 50 end, ruling out the possibility that a 50
extension to the model could uncover a legitimate CDS.
Transcript endpoints can be identified with polyAseq tags,
and these datasets actually suggest that the 30 UTRs of
human and mouse models in GENCODE are frequently too
short. In fact, polyAseq data and regular RNAseq are
readily combined during manual annotation to resolve the
true extent of 30 UTR sequences (Fig. 4b). Furthermore,
using such data, HAVANA has been able to identify and
reclassify dozens of transcripts that were incorrectly clas-
sified as lncRNAs when in fact they represented extended
30 UTRs of upstream protein-coding genes (unpublished
observation). Finally, note that HAVANA annotates
polyadenylation features (both sites and regulatory signals)
Fig. 4 The re-annotation of a protein-coding gene in mouse
GENCODE. a Originally, a single mouse lncRNA transcript
(OTTMUS00000129569; top of diagram) was annotated based on
cDNA AK012899.1 (not shown), creating gene OTTMUS000000
51138. During reappraisal, comparative annotation and RNAseq
analysis showed that the locus is orthologous to human protein-coding
gene NAALADL2 (major transcript OTTHUMT00000347390 is
shown), allowing for the generation of novel mouse protein-coding
transcript OTTMUS00000140064, and the reclassification of OTT-
MUS00000129569 as a non-coding transcript. Split read-supported
introns are shown in blue and green, from David Adams at WTSI
(ArrayExpress ID: E-MTAB-599) and ENCODE, respectively, both
processed by Ensembl. CAGE data from FANTOM5 (DDBJ acces-
sion: DRA000991) support the presence of a TSS for OTT-
MUS00000140064. b While ESTs and RNAseq models did not
allow for the final exon to be annotated with confidence, its structure
could be resolved manually based on RNAseq read coverage graphs
(three examples from David Adams data are shown) alongside
polyAseq data from Derti et al. (Gene Expression Omnibus ID:
GSE30198). Several non-coding EST-based transcripts subsequently
added as models at the 50 end of the locus are not featured. The locus
spans approximately 1 Mb of genomic sequence
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directly onto the genome sequence, and that these features
are not explicitly linked to individual transcript models.
Similarly, at the present time, HAVANA does not annotate
additional transcript models where the only difference is in
the usage of distinct polyadenylation features.
While RNA sequencing methodologies are providing
clear insights into the size of the transcriptome, the size of
the proteome remains far harder to elucidate. For the most
part this is because, while alternative splicing has the
potential to generate large numbers of alternative protein-
isoforms, a minority of alternative transcripts have had
their functionality experimentally confirmed (Mudge et al.
2013). As such, a significant amount of the CDS annotation
in GENCODE is considered ‘putative.’ The underlying
problem is that it is far harder to obtain protein sequences
than it is to obtain RNA or DNA sequences (Faulkner et al.
2015). However, from an annotation perspective at least,
the situation is improving. Firstly, ribosome profiling (RP;
also known as Ribo-seq or ribosome footprinting) provides
a way around the difficulties in dealing with protein
molecules by instead capturing and sequencing fragments
of RNA that are bound to ribosomes (Ingolia et al. 2009;
Ingolia et al. 2011; Lee et al. 2012). This technique can be
modified to specifically map initiation codons, with obvi-
ous potential benefits to annotation pipelines. Nonetheless,
it should be emphasized that RP maps sites of ribosome
occupancy on RNA molecules; it does not obtain actual
protein sequences, and debate about the correct way to
interpret these data is ongoing (Ingolia 2014). At the pre-
sent time, HAVANA only uses RP data to resolve situa-
tions where it is not obvious which initiation codon to use
in a CDS.
Secondly, advances in MS have led to a significant
increase in the number and quality of deduced peptide
sequences becoming available to annotation projects
(Yates 2013; Nesvizhskii 2014), leading to a similar
expansion in the number of repositories to hold such data
(Perez-Riverol et al. 2014). While MS peptides can be used
to validate existing CDS, the greater interest for annotation
projects at the present time is in the discovery of novel
CDS. In fact, a pair of recent publications claimed that
there may be significant numbers of missing protein-coding
genes in the human genome, based on MS-supported novel
translations found in transcribed regions out with the cur-
rent set of protein-coding genes (Kim et al. 2014; Wilhelm
et al. 2014). However, the validity of these interpretations
has been called into question (Ezkurdia et al. 2014). We
believe that both the calling of peptide-spectrum matches
(PSMs) and the mapping of these sequences back to the
genome should be based on highly conservative parameters
(Brosch et al. 2011). Furthermore, the interpretation of
PSM to genome alignments should be subjected to manual
scrutiny. In this way, we observe that PSMs that do not fall
within known protein-coding genes are commonly associ-
ated with pseudogenes. Furthermore, PSMs within pseu-
dogenes or lncRNAs frequently cannot be linked to
canonical initiation codons upstream (unpublished obser-
vations). Essentially, HAVANA does not make protein-
coding genes solely based on MS data where either the
evidence is equivocal or the biological interpretation is
unclear. As a consequence, neither the mouse nor the
human GENCODE genebuilds currently contain ‘orphan’
proteins—i.e., CDS that lacks orthologs or paralogs in
other species—where the only supporting evidence for
translation is PSMs from MS experiments. However,
orphan proteins could theoretically be added to these
genebuilds in the future, provided this annotation is sup-
ported by vigorous functionality based experimental
studies.
New horizons—the annotation of other mouse
strains
To date, mouse GENCODE annotation has focused on the
reference genome of Mus musculus, strain C57BL/6J
(Waterston et al. 2002). However, a major interest in
mouse genomics is to identify differences both between
distinct mouse species and laboratory strains of the same
species. Over the last decade, the HAVANA group has
worked on a number of alternative mouse genomes as part
of external collaborations. For example, candidate Insulin-
dependent diabetes (Idd) regions on six chromosomes have
also been annotated in one or more of the NOD/MrkTac,
NOD/ShiLtJ, and 129 strains (Steward et al. 2013). Today,
researchers have increasing access not just to regions of
alternative mouse genomes, but to the entire genomes
themselves (Yalcin et al. 2012). In particular, the Mouse
Genomes Project is an ongoing effort to provide high-
quality genome sequences for both classical laboratory
strains and wild-derived inbred mice; see Adams et al. in
this issue. While variant sites can be imputed from such
alternative genomes and simply displayed against the ref-
erence mouse genome [for example, using the BioDal-
liance tool at the GENCODE webportal (Down et al.
2011)], the interpretation of such variation is made easier if
alternative annotation models are also available. This is
especially true when considering structural variation,
which has been a focus of comparisons between mouse
genomes (Yalcin et al. 2011; Keane et al. 2014). Annota-
tion projects are particularly interested in large-scale
structural variation, as this phenomenon is often linked to
changes in gene copy number; such events may be of
interest to both medical and evolutionary biologists (Bailey
and Eichler 2006; Chain and Feulner 2014). In our expe-
rience, manual annotation is highly desirable for such
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complex regions; computational analysis pipelines may fail
to interpret the correct evidence for a particular gene copy,
especially where several genes have highly similar
sequences, and may also fail to correctly identify pseudo-
genization events.
For the last few years, the mouse reference assembly has
been improved under the guidance of the Genome Refer-
ence Consortium (GRC) (Church et al. 2011). The first
remit of the GRC is to fix errors and close sequence gaps in
the draft sequence. In the former case, the HAVANA and
RefSeq groups play a key role in identifying indels and
nonsense mutations within mouse protein-coding genes.
These findings are reported to the GRC, and when the
sequence region has been reappraised the results are fed-
back to curators, who update the gene annotation if nec-
essary. For example, a protein-coding gene with a putative
sequencing error may turn out to be a genuine pseudogene.
The GRC also provides alternative assemblies (‘alt loci’) of
regions that are variable between genomes (http://www.
ncbi.nlm.nih.gov/projects/genome/assembly/grc/). The Idd
regions annotated by HAVANA are now included in the
GRC as alt loci. In total, GRCm38.p3—the version of the
mouse reference genome released in March 2014—con-
tains 99 alt loci, featuring sequence from 13 additional
mouse genomes. All alt loci produced by the GRC will be
incorporated into the GENCODE genebuild. In due course,
the complete genome sequences provided by the Keane
group will be added to the mouse GRC repository, and they
will become targets for manual annotation. It is both
unfeasible and unnecessary that each of these genomes will
be subjected to complete manual annotation. We anticipate
that a large proportion of the existing reference assembly
annotation models will simply be ‘lifted across’ between
genomes. Manual annotation will then be employed to
(a) investigate and improve loci that have failed to project
successfully, and (b) to specifically target regions of known
genomic complexity—e.g., dynamically evolving gene
families—where accurate annotation is likely to be par-
ticularly difficult. Furthermore, the manual annotation
process will once again provide an important ‘QC’ service
on these sequences, helping to distinguish true variant sites
from artifacts or errors that arose during the genome
sequencing, assembly, or alignment stages.
Future prospects
The GENCODE annotation of the mouse reference genome
is continuing along several fronts. Firstly, not all gene
features are represented at the present time, in terms of
exons, transcripts, and even whole loci (Mudge et al. 2013;
Cunningham et al. 2015). The mouse GENCODE gene and
transcript counts are thus expected to rise consistently over
the coming years as manual annotation continues and fur-
ther transcript libraries become available. However, while
the number of RNAseq reads available already runs into
the hundreds of millions, concerns have been raised about
the power of this technique to find transcripts with very low
expression levels (Oshlack and Wakefield 2009). Cap-
tureSeq is proving to be highly useful in this regard, being
a method by which transcripts with extremely low
expression can be enriched through the use of tiling arrays
designed across regions of interest (e.g., intragenic space)
prior to high-depth sequencing (Mercer et al. 2012; Clark
et al. 2015). We anticipate that this methodology will be
used to uncover new mouse lncRNAs, in particular those
with restricted expression profiles.
Secondly, a significant amount of work remains to be
done in the functional annotation of the mouse transcrip-
tome, in particular in allowing users to distinguish tran-
scripts that are biologically interesting from those that are
not. While the completion of mouse (or human) functional
annotation cannot be considered a short-term goal, we
anticipate that annotation projects such as GENCODE will
be able to make significant progress over the next few
years. Initially, the completion of currently incomplete
GENCODE models will be of enormous assistance in this
regard. Here, we have outlined methodologies for model
completion that can be carried out at the present time based
on short-read RNAseq coverage graphs and models, as well
as CAGE and polyAseq. However, longer RNAseq read
libraries are becoming available using platforms such as
PacBio (these data are already proving useful for human
annotation (Sharon et al. 2013))—while nanopore-based
RNA sequencing is on the horizon (Clarke et al. 2009)—
and in due course we anticipate that true full-length RNA
sequences will negate the need to combine RNAseq with
separate end-sequencing protocols (Picelli et al. 2014).
Another advantage of NGS is that insights can be
gained into levels of transcription, which can be com-
pared—for example—between tissues or developmental
stages (Wang et al. 2008; Lin et al. 2014). For the human
transcriptome, several projects have already sought to
identify ‘dominant’ transcripts; i.e. the transcript (or pro-
tein) in a particular gene that has the highest, most con-
sistent level of expression (Djebali et al. 2012; Gonzalez-
Porta et al. 2013; Ezkurdia et al. 2015). In the near future,
improvements to RNAseq technologies will complement
the maturation of single-cell protocols, allowing us to
observe changes in transcript expression profiles with
increasing accuracy and resolution. Meanwhile, functional
transcripts can also be extrapolated based on their evolu-
tionary conservation (Fig. 4a). GENCODE is integrating
the output of the APPRIS pipeline, which aims to identify
the ‘principal’ RNA produced by a gene on the basis of
exonic conservation (alongside inferences made into the
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protein structure) (Rodriguez et al. 2013). For mouse and
human GENCODE, the principal APPRIS isoform for each
protein-coding gene is designated in the GTF file, or if no
model matches these strict criteria a single ‘candidate’
model can instead be selected based on its score or length.
We emphasize that such methodologies extrapolate func-
tionality through the use of proxies, and that the true
descriptions of functionality must ultimately come from
single-gene laboratory studies. Even so, we would argue
strongly that annotation projects such as mouse GEN-
CODE must do all they can to provide guidance into
transcript functionality at the present time, given that the
high demand for this information. For example, the
development of the CRISPR/Cas system for genome
engineering is completely changing the landscape of mouse
genomics, offering a simple method by which mouse genes
can be disrupted or switched on and off (Jinek et al. 2012;
Mali et al. 2013; Qi et al. 2013; Wang et al. 2013). How-
ever, uncertainties regarding the functionality of tran-
scriptional complexity within genes, antisense to genes,
and within intragenic space currently represent hurdles to
both the design of CRISPR/Cas assays and the interpreta-
tion of the results produced. In a wider context, gene
annotation will always be an integral component of gen-
ome science, from medical to evolutionary biology. It is
therefore important that all steps are taken to ensure that
genebuilds are as accurate and comprehensive as possible.
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